Children and elderly patients not exceptional to new medical reform programs.

Published: 2001-01-09 11:01:00

Updated: 2001-01-09 11:01:00

In the 4th meeting of the Pharmaceutical Affairs Law Revision Subcommittee on Jan. 4 many issues concerning the current medical and pharmacy reform programs did not make any progress, and were deferred to debate again in the 5th meeting on Jan. 9. It is therefore very likely for the bill unable t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK